ArticleFrontiers in pharmacology2022

Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of F

Luis Fernando Cofas-Vargas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.